If you enjoy this content, please share it with a colleague
RELATED CONTENT
April 28, 2017 — IBA announced the delivery and rigging of three Proteus One treatment rooms in less than a week at ...
April 28, 2017 — IBA (Ion Beam Applications S.A.) announced the Dosimetry Americas division has recently partnered with ...
Independent market research consultancy Robust Insight recently conveyed a survey commissioned by IBA on the state of the proton therapy market entering 2017. The report is based on an online survey among 1,200 hospitals in order to assess how they view proton therapy today and in the future.
IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready Patient QA (quality assurance) and Monitoring solution in the United Kingdom.
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central database and the Cloud. It offers full support throughout all of your QA, and enables you access to the different software modules and all of your data from one intuitive interface – anywhere and anytime.
IBA announced in September that 50,000 patients have been treated by clinical partners using IBA’s proton therapy technology.
IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated patient-centric Ambient Experience solution for the proton therapy gantry of IBA’s Proteus Plus proton therapy solution. The announcement makes the Philips solution now available for both Proteus One and Proteus Plus.
September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined ...
September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the field ...
The global proton therapy market hit a major milestone in 2015, eclipsing the billion-dollar mark for sales orders and more than doubling the previous year’s total, according to market intelligence firm Medraysintell. This boom was evidenced by new proton therapy centers springing up all over the world, including 11 just since November 2015 — eight in the United States and three abroad in Hong Kong, Belgium and the Netherlands.